Monitoring, Switching, and Stopping Multiple Sclerosis Disease-Modifying Therapies.
Article in CONTINUUM Lifelong Learning in Neurology (June 2019)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
Article in Journal of Neurology (September 2017)
Two decades of glatiramer acetate: From initial discovery to the current development of generics
Article in Journal of the Neurological Sciences (March 2017)